![Joanna Horobin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joanna Horobin
Director/Board Member at
LIQUIDIA CORPORATION
Net worth: 3 M $ as of 2026-07-30
Profile
Joanna C.
Horobin is currently an Independent Director at Liquidia Technologies, Inc. since 2019, an Independent Director at Liquidia Corp.
since 2020, and a Member of the Royal College of General Practitioners.
Former roles include Independent Director at Kymera Therapeutics, Inc. from 2018 to 2024, Independent Non-Executive Director at Nordic Nanovector ASA from 2016 to 2023, Independent Director at Vyant Bio, Inc. from 2021 to 2023, Chief Medical Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2015 to 2019, Chief Medical Officer at Verastem, Inc. from 2012 to 2015, President & Director at Syndax Pharmaceuticals, Inc. in 2012, Executive Vice President at CASI Pharmaceuticals, Inc., Chief Operating Officer at CombinatoRx, Inc., Vice President-Oncology at Rhone-Poulenc Rorer, Inc., Director at Nascent Pharmaceuticals, Inc., Director at The University of Manchester, and Non-Executive Chairman at iOnctura SA. Education includes a doctorate from The University of Manchester.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0.04% | 2026-06-15 | 39,637 ( 0.04% ) | 3 M $ | 2026-07-30 |
Joanna Horobin active positions
| Companies | Position | Start |
|---|---|---|
| LIQUIDIA CORPORATION | Director/Board Member | 2020-06-27 |
Royal College of General Practitioners
 Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Director/Board Member | 2019-09-10 |
Former positions of Joanna Horobin
| Companies | Position | End |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 2024-06-17 |
| VYANT BIO, INC. | Director/Board Member | 2023-11-30 |
| THOR MEDICAL | Director/Board Member | 2023-01-02 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Chief Tech/Sci/R&D Officer | 2019-06-30 |
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 2015-06-30 |
Training of Joanna Horobin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Nascent Pharmaceuticals, Inc.
 Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals & drugs | Health Technology |
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Vyant Bio, Inc.
 Vyant Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Stock Market
- Insiders
- Joanna Horobin
